Analgesic prescribing patterns in Norwegian nursing homes from 2000 to 2011: trend analyses of four data samples

Age and Ageing
Reidun SandvikBettina Sandgathe Husebo

Abstract

the analgesic drug use has been reported to increase in general in nursing home patients. However, there is insufficient evidence in terms of what agents are used, variations of use over time and to whom these drugs are prescribed. we investigated the prescribing patterns of scheduled analgesic drugs in Norwegian nursing home patients from 2000 to 2011, with the association to age, gender, cognitive function and type of nursing home unit. secondary analyses of four study samples (three observational studies and one randomised controlled trial). nursing home patients included in study samples from 2000 (n = 1,926), 2004 (n = 1,163), 2009 (n = 850) and 2011 (n = 1,858) located in 14 Norwegian counties. trend analyses of analgesic drug prescriptions. Percentages were described using t-test, χ(2) and Mann-Whitney U test and multivariate logistic regression. the odds ratio for receiving any pain medication in 2011 compared with 2000 was 2.6 (95% CI 2.23-2.91), this is corresponding to a 65% increase from 34.9 to 57.6%. The paracetamol prescription increased by 113%, from 22.7% in 2000 to 48.4% in 2011. Strong opioids (fentanyl, buprenorphine, morphine, oxycodone) increased from 1.9% in 2000 to 17.9% in 2011 (P < 0.001), whereas non-...Continue Reading

References

Jul 7, 1999·Journal of Gerontological Nursing·K S FeldtM B Ryden
Jun 7, 2003·Pain·Sean R MorrisonAlbert L Siu
Sep 28, 2004·International Journal of Geriatric Psychiatry·Oyvind KirkevoldKnut Engedal
Mar 15, 2006·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Debra K WeinerSusan Lieber
Feb 19, 2008·Journal of Pain and Symptom Management·Kimberly S ReynoldsKaren E Steinhauser
Apr 10, 2008·Pharmacoepidemiology and Drug Safety·Hugo LövheimYngve Gustafson
Jul 2, 2008·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Geir SelbaekKnut Engedal
Dec 19, 2008·European Journal of Pain : EJP·Katri HamunenEija Kalso
Apr 21, 2009·Journal of Pain and Symptom Management·David M DosaJoan M Teno
Jun 10, 2009·European Journal of Pain : EJP·Olav Magnus S FredheimPetter C Borchgrevink
Nov 9, 2010·Journal of the American Geriatrics Society·Zachary CordnerBetty S Black
Apr 11, 2012·Nature Reviews. Neurology·Anne CorbettClive Ballard
Feb 27, 2013·Age and Ageing·Aza AbdullaUNKNOWN British Geriatric Society
Nov 10, 2013·Clinical Interventions in Aging·Wilco P AchterbergAnne Corbett
Apr 24, 2014·European Journal of Pain : EJP·C S ZinR D Knaggs
May 7, 2014·European Journal of Pain : EJP·B S HuseboL I Strand
May 9, 2014·International Journal of Geriatric Psychiatry·B S HuseboD Aarsland
Sep 23, 2014·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Christina Jensen-DahmGunhild Waldemar
Nov 7, 2014·Drugs & Aging·Elisabeth FloBettina S Husebo
Jul 4, 2015·Dementia and Geriatric Cognitive Disorders·Anne-Sofie HelvikGeir Selbæk

❮ Previous
Next ❯

Citations

Jan 15, 2016·Age and Ageing·Wilco Achterberg
Jul 8, 2016·Pain Management·Francesca La FrenaisElizabeth L Sampson
Nov 15, 2017·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Charlotte GriffioenWilco P Achterberg
Nov 8, 2017·Drugs -- Real World Outcomes·Natali JokanovicJ Simon Bell
Nov 4, 2017·Scandinavian Journal of Primary Health Care·Amura Francesca FogJørund Straand
Jun 6, 2018·Pharmacoepidemiology and Drug Safety·Jacob N HunnicuttKate L Lapane
Feb 7, 2019·International Journal of Geriatric Psychiatry·Laurna BullockPaul Campbell
May 1, 2019·Expert Opinion on Drug Safety·Ane ErdalBettina Sandgathe Husebo
Jul 20, 2019·Journal of Alzheimer's Disease : JAD·Christina Jensen-DahmGunhild Waldemar
Sep 15, 2020·Der Schmerz·Wilco AchterbergKeela Herr
Sep 25, 2020·Primary Health Care Research & Development·Rasa MikelytePatricia M Wilson
Dec 24, 2017·Journal of the American Geriatrics Society·Francesca L La FrenaisElizabeth L Sampson
Sep 11, 2020·BMC Geriatrics·Amura Francesca FogJørund Straand
Feb 20, 2020·Pain Reports·Wilco AchterbergKeela Herr
Jan 13, 2021·Pain Management Nursing : Official Journal of the American Society of Pain Management Nurses·Shunta WagatsumaRenira C Angeles
Feb 25, 2021·Journal of Pain Research·Wilco P AchterbergStefan Lautenbacher
Mar 16, 2021·International Journal of Geriatric Psychiatry·Francesca La FrenaisElizabeth L Sampson
Jun 5, 2021·Journal of the American Medical Directors Association·Torstein F HabigerBettina S Husebo
Jul 13, 2021·Aging & Mental Health·Anne-Sofie HelvikKjerstin Tevik
Apr 7, 2018·Research in Social & Administrative Pharmacy : RSAP·Julia Fiona-Maree Gilmartin-ThomasJohn McNeil

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The American Journal of Emergency Medicine
Daniel D SingerAdam J Singer
Special Care in Dentistry : Official Publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry
Andrei BaraschGregg H Gilbert
© 2022 Meta ULC. All rights reserved